| DOC | date of conception; deoxycholate; deoxycorticosterone; died of other causes; disorders of cornificat... |
|---|---|
| OND | Ophthalmic Nursing Diploma; orbitonasal dislocation; other neurological disorders |
| PRAGMATIC | pregnancy, rheumatoid arthritis, acromegaly, glucose metabolism disorders, mechanical injury, amyloi... |
| TEN | total enteral nutrition; total excretory nitrogen; toxic epidermal necrolysis; transepidermal neuros... |
| TEWL | transepidermal water loss |
| VCO2 | CO2 elimination |
|---|---|
| GEC | Galactose elimination capacity |
| MIGET | Multiple Inert Gas Elimination Technique |
| T 1/2 | The elimination half life |
| elimination disorders | Excretory-related psychiatric disorders usually diagnosed in infancy or childhood. (12 Dec 1998) |
|---|---|
| other-directed | Pertaining to a person readily influenced by the attitudes of others. (05 Mar 2000) |
| transferases (other substituted phosphate groups) | <enzyme> A class of enzymes that transfers substituted phosphate groups. Registry number: EC 2.7.8 (12 Dec 1998) |
| carbon dioxide elimination | The rate at which carbon dioxide enters the alveolar gas from the blood, equal in the steady state to the metabolic production of carbon dioxide by tissue metabolism throughout the body; units: ml/min STPD or mmol/min. (05 Mar 2000) |
| median time to elimination | <pharmacology> The time it takes one half of a drug to be eliminated from the body. (09 Oct 1997) |
| elimination | <pharmacology> The act of expulsion or of extrusion, especially of drug expulsion from the body. Origin: L. Eliminatio, from limen = threshold (18 Nov 1997) |
| elimination diet | A diet designed to detect what ingredient of the food causes allergic manifestations in the patient; food items to which the patient may be sensitive are withdrawn separately and successively from the diet until that which causes the symptoms is discovered. (05 Mar 2000) |
| elimination half-life | <pharmacology> The time it takes for the body to eliminate or breakdown half of a dose of a pharmacologic agent. (09 Oct 1997) |
| adjustment disorders | Maladaptive reactions to identifiable psychosocial stressors occurring within a short time after onset of the stressor. They are manifested by either impairment in social or occupational functioning or by symptoms (depression, anxiety, etc.) that are in excess of a normal and expected reaction to the stressor. (12 Dec 1998) |
| affective disorders | A class of mental disorder's characterised by a disturbance in mood. (05 Mar 2000) |
| affective disorders, psychotic | Disorders in which the essential feature is a severe disturbance in mood (depression, anxiety, elation, and excitement) accompanied by psychotic symptoms such as delusions, hallucinations, gross impairment in reality testing, etc. (12 Dec 1998) |
| alcohol-related disorders | Mental disorders related or resulting from abuse or mis-use of alcohol. (12 Dec 1998) |
| amphetamine-related disorders | Disorders related or resulting from use of amphetamines. (12 Dec 1998) |
| anxiety disorders | Disorders in which anxiety (persistent feelings of apprehension, tension, or uneasiness) is the predominant disturbance. (12 Dec 1998) |
| articulation disorders | Disorders of speech sound production characterised by substitution, omission, and distortion of sounds. (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|